Testosterone Therapy Shows No Real Impact on Aging Cell Markers in Men
Scientists looked into whether boosting testosterone could slow down aging at the cellular level. They focused on something called telomere length, which are little protective caps found on the ends of chromosomes inside cells. When telomeres get shorter over time, they are often used as a clue that someone is aging faster than expected. The big question was simple: could giving men testosterone help keep those telomeres from shrinking?
The study worked with 720 men between the ages of 50 and 74. Every man who joined had extra weight around the waist and also had trouble managing blood sugar, either with prediabetes or newly found type 2 diabetes. All participants took part in a lifestyle plan focused on healthier living. Then they were split into two random groups. One group got shots of testosterone every three months. The other group got a placebo shot that looked the same but contained no active hormone. Neither the men nor the doctors knew who got which until the study was done.
Researchers measured telomere length at the start of the study and again after two full years. They used a lab method that compares telomere DNA to a control gene. The results were pretty clear. Men who got the testosterone started with an average relative telomere length of about 1.63. After two years, that number barely moved, dropping to 1.61. The placebo group showed almost the same pattern, going from 1.61 down to 1.58. The tiny differences between the two groups were not meaningful enough to count as real change.
When the numbers were crunched with proper math, the difference between testosterone and placebo came out to just 0.01. That number is so small that it could easily happen by chance. The study could not prove that testosterone made any difference at all when it came to telomere length. So the excitement about testosterone acting like an anti-aging treatment took a hit from this research. It seems like the hormone does not protect telomeres in the way some people hoped it might.
One thing to think about is the kind of men who were in this trial. They were older, carried extra weight, and already had blood sugar problems. That matters because aging and metabolism are tied together in complex ways. Maybe in healthier men the results would look different. Or maybe two years was simply not long enough to see any effect at all. The researchers themselves pointed out that bigger studies running for much longer would be needed to really settle the question.